World
Tobacco-Based Coronavirus Vaccine Poised for Human Tests
- First phase of clinical trials could begin as early as June
- Tobacco-made vaccine would contrast with other health effects
This article is for subscribers only.
Sign up here for our daily coronavirus newsletter on what you need to know, and subscribe to our Covid-19 podcast for the latest news and analysis.
An experimental Covid-19 vaccine developed by cigarette maker British American Tobacco Plc is poised to begin testing in humans.